Sciclone Pharma (SCLN) Reports Q3 EPS of $0.24

Sciclone Pharma (NASDAQ: SCLN) reported Q3 EPS of $0.24, versus $0.26 reported last year. Revenue for the quarter came in at $40.5 million, versus $42.9 million reported last year.

For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79